| First Author | Fang P | Year | 2021 |
| Journal | Mol Cell Endocrinol | Volume | 535 |
| Pages | 111369 | PubMed ID | 34171420 |
| Mgi Jnum | J:309728 | Mgi Id | MGI:6759737 |
| Doi | 10.1016/j.mce.2021.111369 | Citation | Fang P, et al. (2021) Development of metabolic dysfunction in mice lacking chemerin. Mol Cell Endocrinol 535:111369 |
| abstractText | Chemerin, an adipocyte-secreted adipokine, is hypothesized to participate in energy homeostasis and glucoregulation. However, the physiologic effect of endogenous chemerin on glucose metabolism is unclear. The present studies tested the hypotheses that chemerin deficiency alters whole-body glucose homeostasis following switches to high-fat diet. Adult, male chemerin knockout and C57BL/6J control wild type mice were studied. During the following 4 weeks, chow- or high-fat diet maintained chemerin knockout mice showed elevated fasting glucose levels and glucose intolerance as well as insulin intolerance. Chemerin deficiency impaired adaptation to glucose and insulin challenge, leading to increased glucose levels. Moreover, the mRNA and protein levels of GLUT4 and PGC-1alpha expression in both skeletal muscle and adipose tissue were significantly decreased in chemerin knockout mice relative to the wild type, respectively. Taken together, the results support the hypotheses that chemerin helps adapt glucose metabolism to changes in dietary fat and modulates glucose consumption in mice by activation of PGC-1alpha/GLUT4 axis. Chemerin may play a significant role in elevation of glucose uptake and insulin sensitivity to promote glucose clearance. |
